Medtronic reports Q2 EPS $1.25, consensus $1.18

Reports Q2 revenue $7.98B, consensus $7.92B. “We’re delivering a track record of durable, mid-single digit revenue growth. The underlying fundamentals are strong, and our solid results were broad-based across our businesses and geographies,” said Geoff Martha, Medtronic chairman and chief executive officer. “We’re bringing game changing innovation to market, with numerous recent regulatory approvals and major product launches, which give us confidence in our ability to continue delivering dependable growth.”